Cash flow Exact Sciences Corporation

Equities

EXAS

US30063P1057

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-11 pm EDT			5-day change	1st Jan Change
51.91 ^USD	-2.64%		-2.72%	-7.62%

Jul. 09	Tariff Drama, Minimal Market Reaction
Jul. 09	Exact Sciences Says Its Oncodetect Test to Detect Colorectal Cancer Gets Medicare Coverage	MT

861d59502b9ccdad87a5f99532.GU_6_RN4POMm3Dcf1_ob2j2mmFjyXkxBYHQh5dtfIIw.eCKKt1AhbqdPrkZbobd8nFPQzSKzMSECKEV-rKwXTf1dOciHIDBFkWTkcg

Published financial data: EXACT SCIENCES CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.49B	1.77B	2.08B	2.5B	2.76B
Total Revenues	1.49B	1.77B	2.08B	2.5B	2.76B
Cost of Goods Sold, Total	354M	459M	574M	654M	840M
Gross Profit	1.14B	1.31B	1.51B	1.85B	1.92B
Selling General & Admin Expenses, Total	1.07B	1.52B	1.64B	1.64B	1.68B
R&D Expenses	554M	386M	393M	426M	431M
Amortization of Goodwill and Intangible Assets - (IS)	93.4M	95M	97.45M	92.16M	-
Other Operating Expenses	-	-	-	-2.03M	-
Other Operating Expenses, Total	1.72B	2B	2.13B	2.15B	2.11B
Operating Income	-582M	-689M	-621M	-309M	-192M
Interest Expense, Total	-95.98M	-18.61M	-19.63M	-19.45M	-27.02M
Interest And Investment Income	6.9M	31.78M	-	32.71M	39.56M
Net Interest Expenses	-89.09M	13.17M	-19.63M	13.27M	12.54M
EBT, Excl. Unusual Items	-671M	-675M	-641M	-296M	-179M
Merger & Related Restructuring Charges	-	-141M	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-19.42M	-	-
Gain (Loss) On Sale Of Assets	-	-	-13.24M	-	-
Asset Writedown	-210M	-20.21M	-15.97M	-621K	-869M
Other Unusual Items	23.66M	-6.36M	56.62M	94.44M	12.54M
EBT, Incl. Unusual Items	-857M	-843M	-633M	-202M	-1.04B
Income Tax Expense	-8.57M	-247M	-9.06M	2.4M	-7.3M
Earnings From Continuing Operations	-849M	-596M	-624M	-204M	-1.03B
Net Income to Company	-849M	-596M	-624M	-204M	-1.03B
Net Income - (IS)	-849M	-596M	-624M	-204M	-1.03B
Net Income to Common Incl Extra Items	-849M	-596M	-624M	-204M	-1.03B
Net Income to Common Excl. Extra Items	-849M	-596M	-624M	-204M	-1.03B
Per Share Items
Net EPS - Basic	-5.61	-3.48	-3.54	-1.13	-5.59
Basic EPS - Continuing Operations	-5.61	-3.48	-3.54	-1.13	-5.59
Basic Weighted Average Shares Outstanding	151M	171M	176M	180M	184M
Net EPS - Diluted	-5.61	-3.48	-3.54	-1.13	-5.59
Diluted EPS - Continuing Operations	-5.61	-3.48	-3.54	-1.13	-5.59
Diluted Weighted Average Shares Outstanding	151M	171M	176M	180M	184M
Normalized Basic EPS	-2.78	-2.46	-2.27	-1.03	-0.61
Normalized Diluted EPS	-2.78	-2.46	-2.27	-1.03	-0.61
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	-419M	-508M	-423M	-102M	23.07M
EBITA	-489M	-594M	-523M	-217M	-96.63M
EBIT	-582M	-689M	-621M	-309M	-192M
EBITDAR	-393M	-471M	-379M	-56.45M	64.96M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	1	29.3	1.43	-1.19	0.7
Current Domestic Taxes	799K	1.39M	2.17M	2.27M	933K
Current Foreign Taxes	933K	4.9M	1.13M	2.56M	1.88M
Total Current Taxes	1.73M	6.29M	3.3M	4.83M	2.82M
Deferred Domestic Taxes	-10.42M	-253M	-12.22M	566K	-9.92M
Deferred Foreign Taxes	120K	54K	-147K	-2.99M	-199K
Total Deferred Taxes	-10.3M	-253M	-12.36M	-2.42M	-10.12M
Normalized Net Income	-419M	-422M	-400M	-185M	-112M
Interest on Long-Term Debt	87.19M	17.16M	16.95M	24.33M	33.97M
Supplemental Operating Expense Items
Advertising Expense	93.2M	144M	170M	138M	180M
Marketing Expenses	134M	194M	238M	184M	213M
Selling and Marketing Expenses	590M	862M	846M	727M	894M
General and Administrative Expenses	482M	654M	794M	911M	785M
Research And Development Expense From Footnotes	846M	470M	393M	426M	431M
Net Rental Expense, Total	25.61M	37.57M	44.75M	45.78M	41.89M
Imputed Operating Lease Interest Expense	14.53M	2.35M	2.89M	2.83M	3.39M
Imputed Operating Lease Depreciation	11.08M	35.22M	41.86M	42.94M	38.5M
Stock-Based Comp., COGS (Total)	-	-	19.22M	20.76M	20.52M
Stock-Based Comp., R&D Exp. (Total)	-	-	33.82M	41.24M	39.68M
Stock-Based Comp., S&M Exp. (Total)	-	-	62.57M	65.55M	68.24M
Stock-Based Comp., G&A Exp. (Total)	-	-	91.21M	104M	86.45M
Stock-Based Comp., Other (Total)	153M	253M	-	-	-
Total Stock-Based Compensation	153M	253M	207M	231M	215M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.49B	315M	242M	605M	601M
Short Term Investments	349M	715M	390M	172M	437M
Total Cash And Short Term Investments	1.84B	1.03B	632M	778M	1.04B
Accounts Receivable, Total	233M	217M	158M	204M	249M
Other Receivables	1.6M	3.2M	5.5M	3.8M	-
Total Receivables	235M	220M	164M	207M	249M
Inventory	92.26M	105M	118M	127M	162M
Prepaid Expenses	31.56M	70.92M	68.1M	81.83M	94.15M
Restricted Cash	-	-	297K	-	-
Other Current Assets, Total	-	-	-	-	27.9M
Total Current Assets	2.2B	1.43B	982M	1.19B	1.57B
Gross Property Plant And Equipment	734M	977M	1.16B	1.27B	1.34B
Accumulated Depreciation	-137M	-215M	-308M	-417M	-509M
Net Property Plant And Equipment	597M	762M	852M	853M	830M
Long-term Investments	29.1M	26.8M	43.7M	51.17M	57.95M
Goodwill	1.24B	2.34B	2.35B	2.37B	2.37B
Other Intangibles, Total	848M	2.11B	1.97B	1.89B	1.01B
Accounts Receivable Long-Term	-	-	-	41.7M	25.9M
Other Long-Term Assets, Total	14.07M	29.59M	36.68M	73.22M	66.07M
Total Assets	4.93B	6.68B	6.23B	6.47B	5.93B
Liabilities
Accounts Payable, Total	35.71M	67.83M	74.92M	78.82M	89.57M
Accrued Expenses, Total	227M	373M	285M	325M	306M
Current Portion of Long-Term Debt	257M	-	-	50M	249M
Current Portion of Leases	16.18M	25.91M	31.57M	33.78M	36.26M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	25M	1M	3.1M	-	-
Other Current Liabilities	15.2M	49.65M	18.41M	27.59M	51.24M
Total Current Liabilities	576M	517M	413M	515M	732M
Long-Term Debt	1.34B	2.18B	2.24B	2.31B	2.32B
Long-Term Leases	135M	195M	190M	169M	169M
Deferred Tax Liability Non Current	19.5M	28.8M	19.7M	17.3M	7.2M
Other Non Current Liabilities	28.08M	376M	325M	311M	296M
Total Liabilities	2.1B	3.3B	3.18B	3.33B	3.53B
Common Stock, Total	1.6M	1.74M	1.78M	1.82M	1.86M
Additional Paid In Capital	4.79B	6.03B	6.31B	6.61B	6.9B
Retained Earnings	-1.97B	-2.64B	-3.27B	-3.47B	-4.5B
Comprehensive Income and Other	526K	-1.44M	-5.24M	1.43M	-944K
Total Common Equity	2.82B	3.39B	3.04B	3.15B	2.4B
Total Equity	2.82B	3.39B	3.04B	3.15B	2.4B
Total Liabilities And Equity	4.93B	6.68B	6.23B	6.47B	5.93B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	169M	174M	178M	182M	186M
ECS Total Common Shares Outstanding	159M	174M	178M	181M	186M
Book Value / Share	17.71	19.51	17.1	17.34	12.94
Tangible Book Value	737M	-1.05B	-1.27B	-1.11B	-974M
Tangible Book Value Per Share	4.63	-6.06	-7.13	-6.13	-5.25
Total Debt	1.75B	2.4B	2.46B	2.57B	2.78B
Net Debt	-88.84M	1.37B	1.83B	1.79B	1.74B
Debt Equivalent Oper. Leases	205M	301M	358M	366M	335M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	43.08M	51.32M	61.21M	58.59M	69.73M
Inventories - Work In Process, Total	49.18M	53.67M	57.05M	68.88M	92.65M
Land - (BS)	4.47M	4.72M	4.72M	4.72M	4.72M
Buildings, Total	201M	211M	289M	291M	291M
Machinery, Total	240M	327M	423M	494M	583M
Full Time Employees	4.8K	6.42K	6.3K	6.5K	6.9K
Part Time Employees	200	80	100	100	100
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-849M	-596M	-624M	-204M	-1.03B
Depreciation & Amortization - CF	69.96M	85.34M	100M	114M	120M
Amortization of Goodwill and Intangible Assets - (CF)	93.4M	95M	97.45M	92.16M	95.16M
Depreciation & Amortization, Total	163M	180M	198M	207M	215M
Amortization of Deferred Charges, Total - (CF)	76.48M	6.68M	7.13M	-	-
(Gain) Loss From Sale Of Asset	2.47M	1.06M	15.11M	-	-
(Gain) Loss on Sale of Investments - (CF)	370K	-24.39M	23.62M	-4.1M	2.71M
Asset Writedown & Restructuring Costs	622M	106M	15.97M	1.12M	869M
Stock-Based Compensation (CF)	153M	253M	207M	231M	215M
Other Operating Activities, Total	9.92M	-140M	-39.88M	-74.33M	-6.51M
Change In Accounts Receivable	-101M	25.15M	61.09M	-43.42M	-46.26M
Change In Inventories	-30.31M	-9.22M	-13.23M	-7.69M	-34.91M
Change In Accounts Payable	55.16M	170M	-52.18M	82.75M	43.54M
Change in Other Net Operating Assets	32.94M	-74.62M	-22.05M	-31.99M	-18.38M
Cash from Operations	136M	-102M	-224M	156M	211M
Capital Expenditure	-64.35M	-136M	-214M	-124M	-136M
Sale of Property, Plant, and Equipment	-	-	25M	-	-
Cash Acquisitions	-418M	-558M	-14.69M	-52.91M	-45M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-219M	-388M	279M	227M	-261M
Other Investing Activities, Total	-381K	-744K	-549K	250K	-225K
Cash from Investing	-702M	-1.08B	74.07M	49.68M	-442M
Long-Term Debt Issued, Total	1.13B	-	-	138M	267M
Total Debt Issued	1.13B	-	-	138M	267M
Long-Term Debt Repaid, Total	-150M	-23.75M	-	-	-50M
Total Debt Repaid	-150M	-23.75M	-	-	-50M
Issuance of Common Stock	907M	37.51M	32.02M	31.54M	32.88M
Other Financing Activities, Total	-3M	-5.29M	44.47M	-9.75M	-17.75M
Cash from Financing	1.88B	8.47M	76.48M	160M	232M
Foreign Exchange Rate Adjustments	-	23K	30K	1.32M	-3.29M
Net Change in Cash	1.31B	-1.18B	-72.98M	367M	-3.04M
Supplemental Items
Cash Interest Paid	9.38M	10.74M	11.52M	18.78M	27.84M
Levered Free Cash Flow	-149M	13.51M	-268M	91.77M	56.18M
Unlevered Free Cash Flow	-165M	18.45M	-263M	104M	73.07M
Change In Net Working Capital	53.18M	-151M	64.42M	16.78M	101M
Net Debt Issued / Repaid	975M	-23.75M	-	138M	217M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-8.63	-7.41	-6.01	-3.04	-1.93
Return on Total Capital	-9.31	-8.3	-6.88	-3.44	-2.2
Return On Equity %	-33.2	-21.18	-19.39	-6.6	-37.09
Return on Common Equity	-33.2	-21.18	-19.39	-6.6	-37.09
Margin Analysis
Gross Profit Margin %	76.24	74.04	72.44	73.83	69.55
SG&A Margin	71.85	85.8	78.68	65.54	60.87
EBITDA Margin %	-28.07	-28.76	-20.31	-4.09	0.84
EBITA Margin %	-32.76	-33.59	-25.11	-8.67	-3.5
EBIT Margin %	-39.03	-38.96	-29.79	-12.35	-6.95
Income From Continuing Operations Margin %	-56.9	-33.71	-29.91	-8.17	-37.29
Net Income Margin %	-56.9	-33.71	-29.91	-8.17	-37.29
Net Avail. For Common Margin %	-56.9	-33.71	-29.91	-8.17	-37.29
Normalized Net Income Margin	-28.12	-23.89	-19.21	-7.39	-4.06
Levered Free Cash Flow Margin	-9.96	0.76	-12.84	3.67	2.04
Unlevered Free Cash Flow Margin	-11.07	1.04	-12.6	4.16	2.65
Asset Turnover
Asset Turnover	0.35	0.3	0.32	0.39	0.44
Fixed Assets Turnover	2.53	2.6	2.57	2.91	3.28
Receivables Turnover (Average Receivables)	8.2	7.86	11.13	13.82	12.19
Inventory Turnover (Average Inventory)	4.6	4.65	5.15	5.32	5.8
Short Term Liquidity
Current Ratio	3.82	2.76	2.38	2.32	2.15
Quick Ratio	3.6	2.42	1.93	1.91	1.76
Operating Cash Flow to Current Liabilities	0.24	-0.2	-0.54	0.3	0.29
Days Sales Outstanding (Average Receivables)	44.61	46.46	32.81	26.4	30.02
Days Outstanding Inventory (Average Inventory)	79.53	78.47	70.93	68.55	63.14
Average Days Payable Outstanding	29.33	40.08	44.33	42.29	35.21
Cash Conversion Cycle (Average Days)	94.81	84.85	59.41	52.66	57.94
Long Term Solvency
Total Debt/Equity	62.02	70.87	80.75	81.6	115.55
Total Debt / Total Capital	38.28	41.48	44.68	44.93	53.61
LT Debt/Equity	52.35	70.11	79.72	78.94	103.67
Long-Term Debt / Total Capital	32.31	41.03	44.1	43.47	48.09
Total Liabilities / Total Assets	42.67	49.32	51.13	51.4	59.48
EBIT / Interest Expense	-6.06	-37	-31.62	-15.88	-7.1
EBITDA / Interest Expense	-4.09	-25.29	-19.28	-2.9	2.4
(EBITDA - Capex) / Interest Expense	-4.77	-32.59	-30.21	-9.29	-2.63
Total Debt / EBITDA	-4.46	-5.1	-6.49	-45.47	42.73
Net Debt / EBITDA	0.23	-2.91	-4.82	-31.69	26.75
Total Debt / (EBITDA - Capex)	-3.83	-3.96	-4.14	-14.21	-39.08
Net Debt / (EBITDA - Capex)	0.19	-2.26	-3.08	-9.9	-24.46
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	70.19	18.49	17.95	19.93	10.36
Gross Profit, 1 Yr. Growth %	72.39	15.06	15.41	22.23	8.88
EBITDA, 1 Yr. Growth %	246.76	21.38	-16.69	-75.85	-122.57
EBITA, 1 Yr. Growth %	215.35	21.47	-11.8	-58.61	-55.4
EBIT, 1 Yr. Growth %	240.4	18.3	-9.82	-50.26	-37.9
Earnings From Cont. Operations, 1 Yr. Growth %	910.24	-27.68	4.68	-67.26	403.97
Net Income, 1 Yr. Growth %	910.24	-27.68	4.68	-67.26	403.97
Normalized Net Income, 1 Yr. Growth %	225.7	4.97	-5.15	-53.86	-39.36
Diluted EPS Before Extra, 1 Yr. Growth %	777.36	-36.21	1.71	-67.95	393.27
Accounts Receivable, 1 Yr. Growth %	78.87	-7.09	-27.05	28.84	22.27
Inventory, 1 Yr. Growth %	49.48	13.8	12.63	7.79	27.38
Net Property, Plant and Equip., 1 Yr. Growth %	2.6	27.75	10.26	-1	-2.69
Total Assets, 1 Yr. Growth %	40.49	35.73	-6.85	3.93	-8.39
Tangible Book Value, 1 Yr. Growth %	-1.36K	-798.17	21.8	-11.67	-12.42
Common Equity, 1 Yr. Growth %	23.4	51.53	-10.17	3.36	-23.62
Cash From Operations, 1 Yr. Growth %	-222.24	-174.91	118.67	-169.83	34.86
Capital Expenditures, 1 Yr. Growth %	-62.54	108.62	57.96	-42.09	9.5
Levered Free Cash Flow, 1 Yr. Growth %	-0.44	-106.53	-2.08K	-133.39	-38.78
Unlevered Free Cash Flow, 1 Yr. Growth %	7.89	-111.13	-1.52K	-139.58	-29.69
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	81.15	42.01	18.22	18.94	15.05
Gross Profit, 2 Yr. CAGR %	83.46	40.84	15.23	18.77	16.12
EBITDA, 2 Yr. CAGR %	75.2	66.4	0.6	-56.09	-77.01
EBITA, 2 Yr. CAGR %	76.45	65.1	3.54	-40.67	-57.57
EBIT, 2 Yr. CAGR %	91.04	71.61	3.32	-34.07	-45.01
Earnings From Cont. Operations, 2 Yr. CAGR %	120.11	67.19	-12.99	-41.46	28.46
Net Income, 2 Yr. CAGR %	120.11	67.19	-12.99	-41.46	28.46
Normalized Net Income, 2 Yr. CAGR %	95.8	28.9	-0.2	-34.9	-47.64
Diluted EPS Before Extra, 2 Yr. CAGR %	97.92	46.33	-19.45	-42.9	25.66
Accounts Receivable, 2 Yr. CAGR %	126.81	28.91	-17.67	-3.05	25.51
Inventory, 2 Yr. CAGR %	53.52	30.42	13.21	10.19	17.18
Net Property, Plant and Equip., 2 Yr. CAGR %	56.05	14.42	19.51	5.09	-1.85
Total Assets, 2 Yr. CAGR %	79.77	38.09	12.44	-1.61	-2.43
Tangible Book Value, 2 Yr. CAGR %	7.79	323.5	190.14	3.32	-12.04
Common Equity, 2 Yr. CAGR %	103.63	21.68	16.67	-3.64	-11.15
Cash From Operations, 2 Yr. CAGR %	40.7	-4.31	27.98	23.57	-2.96
Capital Expenditures, 2 Yr. CAGR %	-34.52	-11.32	81.53	-4.36	-20.37
Levered Free Cash Flow, 2 Yr. CAGR %	4.58	-79.43	13.87	7.64	-55.45
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.04	-69.09	25.94	6.97	-48.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	77.65	57.25	33.49	18.79	16.01
Gross Profit, 3 Yr. CAGR %	82.3	57.04	31.79	17.52	13.61
EBITDA, 3 Yr. CAGR %	59.72	55.03	32.13	-37.48	-64.83
EBITA, 3 Yr. CAGR %	60.89	55.8	33.96	-23.73	-46.06
EBIT, 3 Yr. CAGR %	70.07	62.83	38.49	-19.03	-35.37
Earnings From Cont. Operations, 3 Yr. CAGR %	95.02	50.38	43.03	-37.18	19.99
Net Income, 3 Yr. CAGR %	95.02	50.38	43.03	-37.18	19.99
Normalized Net Income, 3 Yr. CAGR %	80.26	56.84	16.37	-22.83	-36.42
Diluted EPS Before Extra, 3 Yr. CAGR %	78.4	34.36	29.62	-40.75	17.16
Accounts Receivable, 3 Yr. CAGR %	106.66	68.44	6.63	-4.42	4.74
Inventory, 3 Yr. CAGR %	52.48	38.94	24.2	11.38	15.64
Net Property, Plant and Equip., 3 Yr. CAGR %	95.45	45.92	13.54	12.68	2.43
Total Assets, 3 Yr. CAGR %	101.88	63.69	21.1	9.53	-3.93
Tangible Book Value, 3 Yr. CAGR %	14.12	18.37	178.61	94.67	-2.22
Common Equity, 3 Yr. CAGR %	75.72	70.71	9.97	12.05	-10.83
Cash From Operations, 3 Yr. CAGR %	23.92	14.04	26.04	4.58	27.23
Capital Expenditures, 3 Yr. CAGR %	9.9	-3.29	7.5	24.04	0.05
Levered Free Cash Flow, 3 Yr. CAGR %	16.16	-53.67	-5.71	-23.68	-10.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	20.36	-49.28	10.79	-14.38	-7
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	106.79	77.83	50.94	40.63	25.78
Gross Profit, 5 Yr. CAGR %	137.85	89.05	51.74	40.44	23.81
EBITDA, 5 Yr. CAGR %	22.57	26.4	32.73	-5.6	-33.95
EBITA, 5 Yr. CAGR %	25.19	28.59	34.86	6.66	-15
EBIT, 5 Yr. CAGR %	29.62	32.43	39.32	14.13	-3.88
Earnings From Cont. Operations, 5 Yr. CAGR %	39.99	28.93	40.37	3.11	37.01
Net Income, 5 Yr. CAGR %	39.99	28.93	40.37	3.11	37.01
Normalized Net Income, 5 Yr. CAGR %	33.58	32.21	41.09	11.04	-15.1
Diluted EPS Before Extra, 5 Yr. CAGR %	26.8	16.3	29.02	-4.59	28.05
Accounts Receivable, 5 Yr. CAGR %	116.23	90.99	43.01	35.05	13.81
Inventory, 5 Yr. CAGR %	69.08	72.71	35.36	26.63	21.34
Net Property, Plant and Equip., 5 Yr. CAGR %	77.29	82.02	60.5	28.32	7.37
Total Assets, 5 Yr. CAGR %	68.37	77.72	59.75	33.54	11.08
Tangible Book Value, 5 Yr. CAGR %	17.67	25.82	20.66	11.87	75.39
Common Equity, 5 Yr. CAGR %	53.92	58.82	42.36	35.8	0.98
Cash From Operations, 5 Yr. CAGR %	0.37	-4.7	25.53	17.76	13.52
Capital Expenditures, 5 Yr. CAGR %	26.22	55.67	34.63	-3.72	-4.66
Levered Free Cash Flow, 5 Yr. CAGR %	9.07	-30.76	23.08	-7.54	-29.36
Unlevered Free Cash Flow, 5 Yr. CAGR %	11.38	-26.29	22.64	-5.97	-17.66